Retour
Fourchette du Jour
52,55 €
54,19 €
Fourchette 52 Semaines
26,74 €
63,95 €
Volume
1 104 754
Moyenne 50J / 200J
45,08 €
/
39,69 €
Clôture Précédente
54,42 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -12,8 | 0,3 |
| P/B | 7,6 | 2,9 |
| ROE % | -51,8 | 3,7 |
| Net Margin % | -4612,1 | 3,8 |
| Rev Growth 5Y % | -20,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
76,67 €
+43.6%
Low: 44,00 €
High: 100,00 €
BPA Prévisionnel
-4,80 €
CA Est.
4,4 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
5,26 €
-0,12 € – 14,65 €
|
1,3 B | 5 |
| FY2029 |
1,59 €
-0,04 € – 4,43 €
|
790 M | 11 |
| FY2028 |
-2,95 €
-5,82 € – 1,54 €
|
280 M | 13 |
Points Clés
Revenue declined -20,14% annually over 5 years
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -279,92M
Croissance
Revenue Growth (5Y)
-20,14%
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-51,76%
ROIC-47,45%
Net Margin-4612,13%
Op. Margin-4974,27%
Sécurité
Debt / Equity
0,01
Current Ratio13,42
Interest Coverage0,00
Valorisation
P/E Ratio
-12,84
P/B Ratio7,63
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20,14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7,50M | Net Income (TTM) | -345,91M |
| ROE | -51,76% | ROA | -35,24% |
| Gross Margin | 66,09% | Operating Margin | -4974,27% |
| Net Margin | -4612,13% | Free Cash Flow (TTM) | -279,92M |
| ROIC | -47,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 13,42 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -12,84 | P/B Ratio | 7,63 |
| P/S Ratio | 592,09 | PEG Ratio | -0,23 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,44B | Enterprise Value | 4,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,50M | 0,0 | 0,0 | 9,43M | 18,44M |
| Net Income | -345,91M | -234,33M | -182,39M | -125,37M | -78,88M |
| EPS (Diluted) | -4,36 | -3,01 | -2,73 | -2,06 | -1,77 |
| Gross Profit | 4,96M | -2,56M | -167,51M | 9,43M | 18,44M |
| Operating Income | -373,07M | -279,30M | -214,05M | -129,14M | -78,99M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 981,67M | 798,14M | 964,80M | 754,15M | 572,01M |
| Total Liabilities | 399,91M | 43,24M | 36,88M | 32,65M | 21,97M |
| Shareholders' Equity | 581,76M | 754,90M | 927,92M | 721,50M | 550,03M |
| Total Debt | 7,94M | 9,02M | 10,90M | 10,44M | 8,26M |
| Cash & Equivalents | 199,16M | 142,71M | 148,64M | 57,24M | 175,69M |
| Current Assets | 560,65M | 635,26M | 644,96M | 600,30M | 559,02M |
| Current Liabilities | 41,79M | 35,59M | 27,27M | 22,70M | 14,32M |